SC 13G
Amended Statement of Ownership
AYTU BIOPHARMA, INC Filed Acc 0001706226-17-000002
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-08-14 SCHEDULE 13G/A · LYTTON LAURENCE W 4.99%
- 2026-02-17 SCHEDULE 13G/A · LYTTON LAURENCE W 9.99%
- 2026-02-13 SCHEDULE 13G/A · AWM Investment Company, Inc. 5.8%
- 2025-11-14 SCHEDULE 13G/A · LYTTON LAURENCE W 9.99%
- 2025-11-12 SCHEDULE 13G/A · Philotimo Fund, LP 0%
- 2025-08-14 SCHEDULE 13G · AWM Investment Company, Inc. 6.9%
- 2025-08-13 SCHEDULE 13G/A · Stonepine Capital Management, LLC 9.9%
- 2025-06-26 SCHEDULE 13G · Kanen Wealth Management LLC 6.4%
- 2025-06-26 SCHEDULE 13G/A · Kanen Wealth Management LLC 2.7%
- 2025-06-26 SCHEDULE 13G/A · Kanen Wealth Management LLC 10.3%
- 2025-06-26 SCHEDULE 13G · Kanen Wealth Management LLC 6.2%
- 2025-06-13 SCHEDULE 13G · LYTTON LAURENCE W 5.6%
- 2025-06-09 SCHEDULE 13D/A · Nantahala Capital Management, LLC 14.4%
- 2024-11-13 SC 13G/A · Stonepine Capital Management, LLC 9.99%
- 2024-06-18 SC 13D/A · Nantahala Capital Management, LLC 18.2%
- 2024-02-13 SC 13G/A · Stonepine Capital Management, LLC 9.99%
- 2023-06-16 SC 13D/A · Nantahala Capital Management, LLC 19.7%
- 2023-06-16 SC 13G · Stonepine Capital Management, LLC 9.99%
- 2023-05-26 SC 13D · Nantahala Capital Management, LLC 7.2%
- 2023-02-14 SC 13G/A · CVI Investments, Inc. 4.9%
Loading 20170511_AYTU.txt…